Skip Navigation

Faculty Directory

Anne Fortino Rositch, PhD

  • Assistant Professor

Departmental Affiliations

  • Epidemiology (Primary)
    • Division: Cancer Epidemiology
  • School of Medicine (Joint)

Center & Institute Affiliations

Contact Information

615 N. Wolfe Street
Room E6150
Baltimore, Maryland 21205

443-287-5095

View Current Courses

Education

PhD, University of North Carolina at Chapel Hill, 2011
MSPH, University of North Carolina at Chapel Hill, 2008

Overview

Dr. Anne F. Rositch is an applied epidemiologist, concentrating on cancer in women and global cancer disparities, with a background in basic science and experience conducting international field-based research. She received her PhD in Epidemiology from the University of North Carolina at Chapel Hill, and completed a post-doctoral fellowship in Cancer Epidemiology at Johns Hopkins. Currently, Dr. Rositch is an Assistant Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, where she teaches Global Cancer Epidemiology in the Summer Institute and co-Directs the Doctoral Program.

For the last ten years, her research has focused on cervical cancer in HIV-positive individuals, aging women, and in low-resource settings. It has spanned the transnational spectrum from epidemiological studies to understand the natural history of the disease, to studying the effectiveness and implementation of cervical cancer prevention in low-resource settings. Dr. Rositch has ongoing research in Baltimore, South America, and across sub-Saharan Africa. Her recent work is focused on leveraging her training in Implementation Science and experience in cervical cancer prevention to identify novel multidisciplinary and multilevel approaches for breast cancer control in low-resource settings. 

Dr. Rositch's current research program has three main areas: 1) epidemiology and prevention of HPV and invasive cervical cancer in aging and older women; 2) effectiveness and implementation of novel cervical and breast cancer prevention and control programs in high-risk populations and in low-resource settings including Peru, Tanzania, Kenya and South Africa; and 3) cancer and HIV, with a focus on treatment and survival disparities and on defining features of non-AIDS defining cancers in people with HIV/AIDS.

  • Global Cancer epidemiology
  • Cervical cancer
  • Breast cancer
  • Cancer prevention and contol
  • Cancer in HIV/AIDS
  • Implementation Science
  • Cancer disparities and care equity

The papers below highlight the focus and variety of Dr. Rositch's research.

  • Rositch AF, Nowak R, Gravitt PE (2014). Increased age and race-specific incidence of invasive cervical cancer after correction for hysterectomy prevalence in the United States from 2000-2009. Cancer 120(13): 2032-8.
  • Orang’o O, Liu T, Christopherson A, Itsura P, Oguda J, Washington S, Chumba D, Pisharodi L, Cu-Uvin S, Rositch AF (2017). Use of VIA, Pap smear, or HR-HPV testing in women living with HIV/AIDS for post-treatment screening: same tests, different priorities. AIDS 14;31(2):233-240.
  • Rositch AF, Silver MI, Gravitt PE (2014). Cervical cancer screening in older women: new evidence and knowledge gaps. PLOS Medicine 11(1): e1001586.
  • Gravitt PE and Rositch AF (2014). The promise of self-sampling and HPV testing to extend cervical cancer screening coverage. Lancet Oncology pii: S1470-2045(13)70605-3.
  • Rositch AF, Burke A, Viscidi R, Silver MI, Chang K, Gravitt PE (2012). Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acqusition and reactivation in older women. Cancer Research 72(23):6183-90.
  • The Johns Hopkins Center for AIDS Research (JHU CFAR): Rositch, Anne